期刊文献+

人胃癌、肝癌的c-myc癌基因甲基化的研究 被引量:1

Patterns of c-myc oncogene methylation in human gastric and hepatocellular cancer
原文传递
导出
摘要 目的:了解人胃癌和肝癌相关癌基因的甲基化情况。材料与方法:将22例进展期胃癌的癌区、癌旁和外周正常区组织和33例原发性肝癌的癌区、癌旁区及10例正常肝组织的DNA,以限制性内切酶Hpall/Mspl消化、Southernblot分析其c-myc癌基因片段的甲基化情况。结果:发现47%(10/22)的胃癌区、59%(13/22)的胃癌旁和30%(10/33)的肝癌区、13%(4/33)的肝癌旁组织的c-myc癌基因呈低甲基化状态。结论:在消化系常见的恶性肿瘤的发生中,某些癌基因甲基化水平降低。 Objective: To observe the patterns of c-myc oncogene methylation in advanced human gastric and hepatocellular cancer. Methods: The methylation status of c-myc oncogene fragments containing CCGG sequence were digested with endonucleases Hpall/Mspl and analysed by Southern blot in samples from cancerous, paracancerous and non-cancerous tissues in 22 cases of advanced human gastric cancer, and cancerous, paracanerous tissues in 33 cases of hepatocellular carcinoma. Results: The results indicate that c-myc oncogene fragment containing CCGG sequence is hypomethylated of DNA in samples of gastric cancer (47%), paracancerous tissue (59%), and in hepatocellular carcinoma (30%), as wellas its paracancerous tissue (13%).Conclusion:The levels of c-myc oncogene methylation are reduced in human gastric and hepatocellular carcinogenesis.
出处 《中华消化杂志》 CAS CSCD 北大核心 1997年第1期4-6,共3页 Chinese Journal of Digestion
基金 国家自然科学基金
关键词 胃肿瘤 肝肿瘤 DNA甲基化 C-MYC基因 Gastric cancer Hepatocellular carcinoma DNA methylation c-myc oncogene
  • 相关文献

参考文献4

  • 1房静远,上海医学,1996年,19卷,1页
  • 2房静远,J Gastroenterol Hepatol,1995年,10卷,Suppl期,A119页
  • 3陆东东,国外医学.肿瘤学分册,1995年,22卷,增刊,184页
  • 4Peng S Y,Hepatol,1993年,17卷,35页

同被引文献71

  • 1杨丽,房静远,陈萦晅,陆娟,朱红音,沈冠凤,罗鸿仔.甲基化修饰对人胃癌细胞系中多种基因的调控[J].胃肠病学,2003,8(2):70-74. 被引量:3
  • 2杨定成,李通,吕有勇,张青云,李诤,谢山海,李文梅.C-Ha-ras癌基因低甲基化在胃癌形成中的作用[J].北京医科大学学报,1994,26(2):102-104. 被引量:7
  • 3Baylin SB, Herman JG, Graft JR, Vertino PM, Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia.Adv Cancer Res 1998; 72: 141-196.
  • 4Baylin SB. Reversal of gene silencing as a therapeutic target for cancer-roles for DNA methylation and its interdigitation with chromatin. Novartis Found Symp 2004; 259:226-233.
  • 5Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM, Jones PA. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.Cancer Res 1995; 55:4531-4535.
  • 6Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, Sidransky D, Baylin SB. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995; 55:4525-4530.
  • 7Galm O, Wilop S, Reichelt J, Jost E, Gehbauer G, Herman JG,Osieka R. DNA methylation changes in multiple myeloma.Leukemia 2004; 18:1687-1692.
  • 8Gilbert J, Gore SD, Herman JG, Carducci MA. The clinical application of targeting cancer through histone acetylation and hypomethylation. Clin Cancer Res 2004; 10:4589-4596.
  • 9Herman JG. Circulating methylated DNA. Ann N Y Acad Sci 2004; 1022:33-39.
  • 10Herman JG. Epigenetics in lung cancer: focus on progression and early lesions. Chest 2004; 125: 119S-122S.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部